The Effect of Rosuvastatin on Facial Nerve Regeneration After Facial Nerve Injury: An Experimental Animal Study
Annals of Otology, Rhinology & Laryngology · 2025
DOI: 10.1177/00034894241291814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Otology, Rhinology & Laryngology, 2025. Verfasst von Uğur Dincer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of ENT, Reyhanli State Hospital, Hatay, Turkey. Hauptthemen laut MEDLINE: Rosuvastatin Calcium, Nerve Regeneration, Facial Nerve Injuries, Rats, Sprague-Dawley. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Sağlık Bilimleri Üniversitesi.
Abstract (Originalsprache)
Objectives
Rosuvastatin is an antihyperlipidemic statin group pharmacological agent with antioxidant, neuroprotective, and anti-inflammatory effects. In this study, we aimed to examine the functional, electrophysiological, and histopathological effects of rosuvastatin or in combination with corticosteroids on facial nerve regeneration in rats with traumatic peripheral facial paralysis (PFP).
Methods
PFP was induced in 28 female Sprague Dawley rats that we divided into 4 groups: group 1, control group; group 2, methylprednisolone group; group 3, rosuvastatin group; group 4, rosuvastatin and methylprednisolone group. Electrophysiological, functional, and histopathological examinations were performed before and after the medications.
Results
Electrophysiological threshold values of group 3 and group 4 were found to be significantly lower than the control group on day 21 after treatment ( P = .002, P = .001; P < .01).In the histopathological evaluation, axonal degeneration, macrovacuolization, and vascular congestion levels were compared between the groups, and a statistically significant difference was observed in group 4 compared to the control group. The recovery time of the eye corneal reflex was found to be significantly higher in the control group than in groups 3 and 4 when comparing postoperative day 1 to day 7 and postoperative day 1 to day 14.
Conclusion
Rosuvastatin, especially when combined with methylprednisolone was found to significantly increase the facial nerve electrophysiological, functional, and histopathological recovery in injury-induced traumatic PFP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of ENT, Reyhanli State Hospital, Hatay, Turkey.
- Department of ENT, Haydarpaşa Numune Training and Research Hospital, University of Health Science, İstanbul, Turkey.
- Department of ENT, Kemalpaşa State Hospital, İzmir, Turkey.
- Department of Pathology,Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital, University of Health Science, İstanbul, Turkey.
ORCID-Profile: Uğur Dincer, Çağrı Becerik
Förderung
- Sağlık Bilimleri Üniversitesi
Zitieren
APA
Dincer, U., Verim, A., Becerik, Ç., Gürsan, N., Tepe Karaca, Ç., & Toros, S. Z. (2025). The Effect of Rosuvastatin on Facial Nerve Regeneration After Facial Nerve Injury: An Experimental Animal Study. Annals of Otology, Rhinology & Laryngology. https://doi.org/10.1177/00034894241291814
Vancouver
Dincer U, Verim A, Becerik Ç, Gürsan N, Tepe Karaca Ç, Toros SZ. The Effect of Rosuvastatin on Facial Nerve Regeneration After Facial Nerve Injury: An Experimental Animal Study. Annals of Otology, Rhinology & Laryngology. 2025. doi:10.1177/00034894241291814
BibTeX
@article{Dincer2025,
author = {Dincer, Uğur and Verim, Ayşegül and Becerik, Çağrı and Gürsan, Nilüfer and Tepe Karaca, Çiğdem and Toros, Sema Zer},
title = {The Effect of Rosuvastatin on Facial Nerve Regeneration After Facial Nerve Injury: An Experimental Animal Study},
journal = {Annals of Otology, Rhinology & Laryngology},
year = {2025},
doi = {10.1177/00034894241291814}
}
EUVIMED